238.6K XNAS Volume
XNAS 20 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 26,250 | 26,250 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 5,625 | 5,625 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 7,850 | 7,850 | - | - | Employee Stock Option (right to buy) | |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 9,375 | 9,375 | - | - | Employee Stock Option (right to buy) | |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 7,850 | 7,850 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 7,850 | 7,850 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 6,875 | 6,875 | - | - | Employee Stock Option (right to buy) | |
Mark W. Frohlich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 04 Feb 2025 | 4,952 | 243,854 (0%) | 0% | 20.9 | 103,601 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 04 Feb 2025 | 4,400 | 239,454 (0%) | 0% | 21.9 | 96,474 | Common Stock |
Dean Schorno | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 04 Feb 2025 | 1,734 | 57,235 (0%) | 0% | 21.9 | 38,020 | Common Stock |
Dean Schorno | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 04 Feb 2025 | 2,036 | 58,969 (0%) | 0% | 20.9 | 42,595 | Common Stock |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 04 Feb 2025 | 1,339 | 38,830 (0%) | 0% | 21.9 | 29,359 | Common Stock |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 04 Feb 2025 | 1,448 | 40,169 (0%) | 0% | 20.9 | 30,294 | Common Stock |
David A. Santos | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 04 Feb 2025 | 1,796 | 51,704 (0%) | 0% | 21.9 | 39,379 | Common Stock |
David A. Santos | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 04 Feb 2025 | 2,125 | 53,500 (0%) | 0% | 20.9 | 44,457 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 63,400 | 63,400 | - | - | Employee Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 42,300 | 248,806 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 19,717 | 61,005 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 14,788 | 14,788 | - | - | Employee Stock Option (Right to Buy) | |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 14,788 | 14,788 | - | - | Employee Stock Option (Right to Buy) | |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 19,717 | 41,617 (0%) | 0% | 0 | Common Stock | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 19,717 | 55,625 (0%) | 0% | 0 | Common Stock | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 14,788 | 14,788 | - | - | Employee Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.40 per share. | 24 Jan 2025 | 45,000 | 249,662 (0%) | 0% | 21.4 | 963,000 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.17 per share. | 24 Jan 2025 | 44,078 | 205,584 (0%) | 0% | 22.2 | 977,209 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.40 per share. | 24 Jan 2025 | 45,000 | 250,584 (0%) | 0% | 21.4 | 963,000 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.17 per share. | 24 Jan 2025 | 44,078 | 206,506 (0%) | 0% | 22.2 | 977,209 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 45,000 | 0 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 45,000 | 0 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 6,250 | 6,250 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 8,000 | 8,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 32,500 | 32,500 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 102,222 (0%) | 0% | 0 | Common Stock | |
Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Alison L. Hannah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Alison L. Hannah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 81,250 (0%) | 0% | 0 | Common Stock | |
Kamil Ali-Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Kamil Ali-Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 68,750 (0%) | 0% | 0 | Common Stock | |
Brian L. Kotzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 78,500 | 78,500 | - | - | Employee Stock Option (right to buy) | |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 78,500 | 78,500 | - | - | Employee Stock Option (right to buy) | |
Raymond J. Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 93,750 | 93,750 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 78,500 | 78,500 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
A. David Santos | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 02 Feb 2024 | 8,918 | 349,093 (0%) | 0% | 1.1 | 10,167 | Common Stock |
A. Santos David | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 02 Feb 2024 | 5,601 | 358,011 (0%) | 0% | 1.1 | 6,329 | Common Stock |
R. Raul Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 02 Feb 2024 | 22,349 | 2,067,174 (1%) | 0% | 1.1 | 25,261 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 02 Feb 2024 | 30,545 | 2,036,629 (1%) | 0% | 1.1 | 34,821 | Common Stock |
Dean Schorno | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 02 Feb 2024 | 5,601 | 409,918 (0%) | 0% | 1.1 | 6,327 | Common Stock |
Dean Schorno | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 02 Feb 2024 | 7,027 | 402,891 (0%) | 0% | 1.1 | 8,011 | Common Stock |
R. Raul Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 400,000 | 2,089,523 (1%) | 0% | 0 | Common Stock | |
Rodriguez R. Raul | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (Right to Buy) | |
J. Raymond Furey | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 209,000 | 214,000 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 209,000 | 415,519 (0%) | 0% | 0 | Common Stock | |
Furey Raymond J. | EVP, GC, CCO & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 157,000 | 157,000 | - | - | Employee Stock Option (Right to Buy) | |
A. David Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 209,000 | 363,612 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 157,000 | 157,000 | - | - | Employee Stock Option (Right to Buy) | |
David Santos A. | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 157,000 | 157,000 | - | - | Employee Stock Option (Right to Buy) | |
Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 77,222 (0%) | 0% | 0 | Common Stock | |
Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
Alison L. Hannah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 56,250 (0%) | 0% | 0 | Common Stock | |
Alison L. Hannah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Kamil Ali-Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Kamil Ali-Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 43,750 (0%) | 0% | 0 | Common Stock | |
Brian L. Kotzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 02 Feb 2023 | 5,389 | 196,519 (0%) | 0% | 1.7 | 8,946 | Common Stock |
Wolfgang Dummer | EVP & CMO | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 02 Feb 2023 | 5,389 | 72,459 (0%) | 0% | 1.7 | 8,946 | Common Stock |
David A. Santos | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 02 Feb 2023 | 5,388 | 144,612 (0%) | 0% | 1.7 | 8,945 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 300,000 | 1,701,053 (1%) | 0% | 0 | Common Stock | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 200,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 26 Jan 2023 | 20,340 | 1,680,713 (0%) | 0% | 1.8 | 35,595 | Common Stock |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 50,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 63,000 | 201,908 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
Wolfgang Dummer | EVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 50,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 160,000 | 160,000 | - | - | Employee Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 80,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 50,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 81,250 | 81,250 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 81,250 | 81,250 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 09 Jun 2022 | 1,000,000 | 1,391,776 (0%) | 0% | 0.7 | 688,400 | Common Stock |
Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
Gary A. Lyons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
Jane Wasman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 52,222 (0%) | 0% | 0 | Common Stock | |
Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
Gregg Anthony Lapointe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Alison L. Hannah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 31,250 (0%) | 0% | 0 | Common Stock | |
Alison L. Hannah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Kamil Ali-Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 18,750 | 18,750 (0%) | 0% | 0 | Common Stock | |
Kamil Ali-Jackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
Brian L. Kotzin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 50,000 | 60,260 (0%) | 0% | 0 | Common Stock | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 200,000 | 391,776 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 50,000 | 128,908 (0%) | 0% | 0 | Common Stock | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Wolfgang Dummer | EVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 50,000 | 67,848 (0%) | 0% | 0 | Common Stock | |
Wolfgang Dummer | EVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 50,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 125,000 | 125,000 | - | - | Stock Option(right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 525,000 | 525,000 | - | - | Stock Option(right to buy) | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 112,500 | 112,500 | - | - | Stock Option(right to buy) | |
Wolfgang Dummer | EVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 125,000 | 125,000 | - | - | Stock Option(right to buy) | |
Wolfgang Dummer | EVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 37,500 | 37,500 | - | - | Stock Option (right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 137,500 | 137,500 | - | - | Stock Option(right to buy) | |
David A. Santos | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2020 | 250,000 | 250,000 | - | - | Employee Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Jane Wasman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Keith A. Katkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Gregg Anthony Lapointe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Nelson Cabatuan | VP,Finance & Princ.Acctg. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2020 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2020 | 650,000 | 650,000 | - | - | Stock Option (right to buy) | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2020 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
Nelson Cabatuan | VP,Finance & Princ.Acctg. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2020 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2019 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2019 | 237,500 | 237,500 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2019 | 83,750 | 83,750 | - | - | Employee Stock Option (right to buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2019 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2019 | 43,750 | 43,750 | - | - | Employee Stock Option (right to buy) | |
Esteban Masuda | Sr. VP Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Nov 2019 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
Wolfgang Dummer | EVP & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2019 | 220,000 | 220,000 | - | - | Employee Stock Option (right to buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Jane Wasman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 13,750 | 13,750 | - | - | Stock Option (Right to Buy) | |
Keith A. Katkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Gregg Anthony Lapointe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Dean Schorno | EVP &Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 22 May 2019 | 3,274 | 50,000 (0%) | 0% | 2.1 | 6,971 | Common Stock |
Dean Schorno | EVP &Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 22 May 2019 | 46,726 | 46,726 (0%) | 0% | 2.1 | 99,573 | Common Stock |
Jane Wasman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 80,000 | 80,000 | - | - | Stock Option ( Right to Buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 237,500 | 237,500 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 83,750 | 83,750 | - | - | Employee Stock Option (right to buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 43,750 | 43,750 | - | - | Employee Stock Option (right to buy) | |
Esteban Masuda | Sr. VP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
Stacy Markel | EVP Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 162,500 | 162,500 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 162,500 | 162,500 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 162,500 | 162,500 | - | - | Employee Stock Option (right to buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
Joseph Lasaga | Sr.VP Bus.Dev.Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Esteban Masuda | Sr. VP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Nelson Cabatuan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
Stacy Markel | EVP Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 137,500 | 137,500 | - | - | Employee Stock Option (right to buy) | |
Nelson Cabatuan | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 12 Oct 2018 | 10,000 | 58 (0%) | 0% | 3.1 | 31,200 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 17 Sep 2018 | 37,500 | 0 (0%) | 0% | 3.5 | 131,250 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 17 Sep 2018 | 37,500 | 37,500 (0%) | 0% | 2.1 | 79,125 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.50 per share. | 17 Sep 2018 | 115,500 | 0 (0%) | 0% | 3.5 | 404,250 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 17 Sep 2018 | 115,500 | 115,500 (0%) | 0% | 2.5 | 293,370 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2018 | 115,500 | 268,000 | - | - | Employe Stock Option (right to buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2018 | 37,500 | 112,500 | - | - | Employee Stock Option (right to buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 10 Sep 2018 | 50,000 | 165,000 (0%) | 0% | 3.3 | 164,210 | Common Stock |
Eldon C. Mayer | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 10 Sep 2018 | 50,000 | 215,000 (0%) | 0% | 3.2 | 161,340 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2018 | 16,500 | 383,500 | - | - | Employe Stock Option (right to buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.51 per share. | 04 Sep 2018 | 16,500 | 0 (0%) | 0% | 3.5 | 57,861 | Common Stock |
Anne-Marie Duliege | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 04 Sep 2018 | 16,500 | 16,500 (0%) | 0% | 2.5 | 41,910 | Common Stock |
Eldon C. Mayer | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 23 Aug 2018 | 100,000 | 115,000 (0%) | 0% | 2.8 | 282,320 | Common Stock |
Raul R. Rodriguez | Director, CEO, President | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 17 Aug 2018 | 114,000 | 173,519 (0%) | 0% | 2.6 | 300,002 | Common Stock |
Nelson Cabatuan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.79 per share. | 02 Jul 2018 | 5,000 | 0 (0%) | 0% | 2.8 | 13,932 | Common Stock |
Dean Schorno | EVP &Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2018 | 167,500 | 167,500 | - | - | Employee Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Keith A. Katkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Gregg Anthony Lapointe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2018 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2018 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2018 | 450,000 | 450,000 | - | - | Employee Stock Option (Right to Buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2018 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
Joseph Lasaga | VP Bus. Dev.& Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2018 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
Esteban Masuda | Sr. VP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2018 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
Anne-Marie Duliege | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.11 per share. | 20 Apr 2018 | 5,000 | 0 (0%) | 0% | 4.1 | 20,550 | Common Stock |
Stacy Markel | EVP Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2018 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
Anne-Marie Duliege | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 475,000 | 475,000 | - | - | Employee Stock Option (right to buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
Joseph Lasaga | VP Bus. Dev.& Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 87,500 | 87,500 | - | - | Employee Stock Option (right to buy) | |
Esteban Masuda | Sr. VP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
Nelson Cabatuan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 24,000 | 24,000 | - | - | Employee Stock Option (right to buy) | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2017 | 100,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 3.90 per share. | 03 Nov 2017 | 100,000 | 0 (0%) | 0% | 3.9 | 390,000 | Common Stock |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 03 Nov 2017 | 100,000 | 100,000 (0%) | 0% | 2.1 | 214,000 | Common Stock |
Gregg Anthony Lapointe | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2017 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Brian L. Kotzin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2017 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Anne-Marie Duliege | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 05 Jul 2017 | 5,000 | 0 (0%) | 0% | 2.7 | 13,427 | Common Stock |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2017 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2017 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Keith A. Katkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2017 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2017 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2017 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2017 | 62,500 | 62,500 | - | - | Employee Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2017 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2017 | 400,000 | 400,000 | - | - | Employee Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2017 | 75,000 | 75,000 | - | - | Employee Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2017 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2017 | 62,500 | 62,500 | - | - | Employee Stock Option (Right to Buy) | |
Anne-Marie Duliege | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Eldon C. Mayer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Joseph Lasaga | VP Bus. Dev.& Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Esteban Masuda | Sr. VP Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Anne-Marie Duliege | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.41 per share. | 03 Jan 2017 | 5,000 | 0 (0%) | 0% | 2.4 | 12,028 | Common Stock |
Eldon C. Mayer | EVP &Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2016 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) | |
Joseph Lasaga | VP Bus. Dev.& Alliance Mgmt. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2016 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Aug 2016 | 5,303 | 53,031 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2016 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2016 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2016 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2016 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2016 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Keith A. Katkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2016 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Anne-Marie Duliege | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2016 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2016 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Keith A. Katkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Jun 2015 | 41,666 | 58,334 | - | - | Common Stock | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 41,666 | 100,000 | - | - | Common Stock | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2015 | 41,666 | 158,334 | - | - | Stock Option (Right to Buy) | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2015 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2015 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2015 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2015 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2015 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Apr 2015 | 10,000 | 58,334 | - | - | Common Stock | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2015 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2015 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2015 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2015 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2015 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Dec 2014 | 1,000 | 575 | - | - | Common Stock | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Sep 2014 | 20,000 | 68,334 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2014 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2014 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2014 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2014 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2014 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2014 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2014 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2014 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2014 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2014 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2014 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Feb 2014 | 20,000 | 88,334 | - | - | Common Stock | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2013 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2013 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2013 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2013 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2013 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2013 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Sep 2012 | 4,151 | 1,103 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2012 | 23,302 | 73,300 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2012 | 23,302 | 23,302 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Sep 2012 | 23,302 | 0 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2012 | 34,112 | 34,112 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Sep 2012 | 34,112 | 0 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2012 | 17,586 | 17,586 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Sep 2012 | 17,586 | 0 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2012 | 34,112 | 114,188 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2012 | 17,586 | 96,602 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2012 | 1,700 | 1,700 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Aug 2012 | 700 | 1,000 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Aug 2012 | 100 | 900 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Aug 2012 | 600 | 300 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Aug 2012 | 300 | 0 | - | - | Common Stock | |
Ryan D. Maynard | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2012 | 1,700 | 148,300 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jun 2012 | 100 | 118,234 | - | - | Common Stock | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jun 2012 | 100 | 118,134 | - | - | Common Stock | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jun 2012 | 9,700 | 108,434 | - | - | Common Stock | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jun 2012 | 100 | 108,334 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2012 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2012 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2012 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2012 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2012 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2012 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2012 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2012 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2012 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2012 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2012 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2012 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 46,524 | 470,425 | - | - | Common Stock | |
Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 72,800 | 762,700 | - | - | Common Stock | |
Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 229,252 | 2,279,997 | - | - | Common Stock | |
Flynn E James | Other | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 May 2011 | 301,424 | 3,204,167 | - | - | Common Stock | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2011 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2011 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2011 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2011 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2011 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2011 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2011 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2010 | 2,605 | 2,050,745 | - | - | Common Stock | |
Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2010 | 3,690 | 2,902,743 | - | - | Common Stock | |
Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2010 | 516 | 423,901 | - | - | Common Stock | |
Flynn E James | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Nov 2010 | 900 | 689,900 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2010 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | EVP Corp. Affairs, G.C., Sect. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2010 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2010 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2010 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | SVP, Gen. Counsel, Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2010 | 105,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2010 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2010 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2010 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2010 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2010 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2009 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | SVP, Gen. Counsel, Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2009 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2009 | 145,000 | 145,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2009 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2009 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2009 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2009 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2009 | 3,334 | 0 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2009 | 3,334 | 118,334 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | SVP, Gen. Counsel, Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, EVP, Pres. Discovery&Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | EVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2008 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 300 | 300 | - | - | Common Stock | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 100 | 400 | - | - | Common Stock | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 600 | 1,000 | - | - | Common Stock | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 800 | 1,800 | - | - | Common Stock | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 1,385 | 3,185 | - | - | Common Stock | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 1,815 | 5,000 | - | - | Common Stock | |
Bradford S. Goodwin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Aug 2007 | 5,000 | 10,000 | - | - | Common Stock | |
Walter H. Moos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2007 | 2,222 | 0 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2007 | 2,222 | 2,222 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2007 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | Sr. VP Medical Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 May 2007 | 2,000 | 2,000 | - | - | Common Stock | |
Dolly A. Vance | SVP, Gen. Counsel, Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 103,788 | 103,788 | - | - | Stock Option (right to buy) | |
Donald G. Payan | Director, Ex. VP Chief Sci. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Elliott B. Grossbard | Sr. VP Medical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Ryan D. Maynard | VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2007 | 106,911 | 106,911 | - | - | Stock Option (right to buy) | |
Bradford S. Goodwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2007 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 4,039 | 4,039 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 1,112 | 1,112 | - | - | Stock Option (Right to Buy) | |
Alan D. Frazier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 556 | 556 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 16,249 | 16,249 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | Sr. VP Medical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 27,778 | 27,778 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 43,889 | 43,889 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 1,112 | 1,112 | - | - | Stock Option (Right to Buy) | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 1,111 | 1,111 | - | - | Stock Option (Right to Buy) | |
Ryan D. Maynard | VP Finance, Acting CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2006 | 1,000 | 1,000 | - | - | Stock Option (Right to Buy) | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Alan D. Frazier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2006 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
Donald G. Payan | Director, Ex. VP Chief Sci. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
Elliott B. Grossbard | Sr. VP Medical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
James H. Welch | CFO, VP & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2006 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Alan D. Frazier | None | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2005 | 10,905 | 0 | - | - | Common Stock | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Dec 2005 | 1,000 | 9,000 | - | - | Common Stock | |
Jean Deleage | None | Other type of transaction at price $ 0.00 per share. | 02 Nov 2005 | 315,423 | 0 | - | - | Common Stock | |
Jean Deleage | None | Other type of transaction at price $ 0.00 per share. | 02 Nov 2005 | 11,604 | 0 | - | - | Common Stock | |
Jean Deleage | None | Other type of transaction at price $ 0.00 per share. | 02 Nov 2005 | 697 | 697 | - | - | Common Stock | |
James M. Gower | Director, CEO & Board Chairman | Other type of transaction at price $ 0.00 per share. | 02 Nov 2005 | 297 | 126,736 | - | - | Common Stock | |
James M. Gower | Director, CEO & Board Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2005 | 50,000 | 180,676 | - | - | Common Stock | |
James M. Gower | Director, CEO & Board Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2005 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
Gary A. Lyons | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2005 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, Ex. VP Chief Sci. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 93,000 | 93,000 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | Sr. VP Medical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
James H. Welch | CFO, VP & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2005 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Jul 2005 | 122,684 | 358,633 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Jul 2005 | 4,513 | 13,194 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Jul 2005 | 43,210 | 315,423 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Jul 2005 | 1,590 | 11,604 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jul 2005 | 6,173 | 481,317 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Jul 2005 | 227 | 17,707 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Jul 2005 | 565 | 487,490 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Jul 2005 | 21 | 17,934 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jul 2005 | 34,153 | 596,692 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jul 2005 | 1,256 | 21,952 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jul 2005 | 108,637 | 488,055 | - | - | Common Stock | |
Jean Deleage | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Jul 2005 | 3,997 | 17,955 | - | - | Common Stock | |
Stephen A. Sherwin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Hollings C. Renton | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Nicholas J. Simon | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Jean Deleage | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Alan D. Frazier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Walter H. Moos | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2005 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2005 | 15,000 | 19,385 | - | - | Common Stock | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 May 2005 | 15,000 | 4,385 | - | - | Common Stock | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2005 | 15,000 | 16,249 | - | - | Employee Stock Option (right to buy) | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Mar 2005 | 1,000 | 4,385 | - | - | Common Stock | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Feb 2005 | 200 | 7,700 | - | - | Common Stock | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Feb 2005 | 300 | 8,000 | - | - | Common Stock | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2005 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) | |
Peter S. Ringrose | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2005 | 6,667 | 6,667 | - | - | Stock Option (Right to Buy) | |
Alan D. Frazier | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Jan 2005 | 2,332 | 0 | - | - | Common Stock | |
Alan D. Frazier | None | Other type of transaction at price $ 0.00 per share. | 24 Jan 2005 | 459,563 | 0 | - | - | Common Stock | |
Alan D. Frazier | None | Other type of transaction at price $ 0.00 per share. | 24 Jan 2005 | 481,396 | 0 | - | - | Common Stock | |
Alan D. Frazier | None | Other type of transaction at price $ 0.00 per share. | 24 Jan 2005 | 4,917 | 10,905 | - | - | Common Stock | |
Dolly A. Vance | VP Intel. Prop.& Gen.Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 38,751 | 38,751 | - | - | Stock Option (Right to Buy) | |
Donald G. Payan | Director, Ex. VP Chief Sci. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
Elliott B. Grossbard | Sr. VP Medical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 32,222 | 32,222 | - | - | Stock Option (Right to Buy) | |
James H. Welch | CFO, VP & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 27,777 | 27,777 | - | - | Stock Option (Right to Buy) | |
James M. Gower | Director, CEO & Board Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Raul R. Rodriguez | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Robin D.G. Cooper | Sr. V.P. Pharmaceutical Scs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2005 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
Dennis Henner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Jan 2005 | 1,700 | 1,715 | - | - | Common Stock | |
Dennis Henner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Jan 2005 | 200 | 1,515 | - | - | Common Stock | |
Dennis Henner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Jan 2005 | 100 | 1,415 | - | - | Common Stock |